Stocks making the biggest moves midday: Nvidia, Exact Sciences, Walmart, Strategy, Regeneron

Check out the companies making headlines in midday trading: Nvidia — The chipmaker fell nearly 2%, reversing earlier gains after it reported fiscal third-quarter results that were well above expectations. Nvidia’s fourth-quarter revenue guidance was also stronger than analysts anticipated. As Nvida’s stock faltered a number of other AI trades fell as well including Palantir Technologies , which fell nearly 6%, which AMD and Super Micro Computer each slipped about 5%. Exact Sciences — The maker of Cologuard diagnostic tests to detect colorectal cancer jumped 17% after Abbott Laboratories agreed to a $105-per-share cash buyout valued at some $21 billion. The deal is expected to close in the second quarter of 2026. Abbott edged down 1%. Crypto stocks — With bitcoin’s value continuing to tumble on Thursday along with rate-cut hopes, stocks tied to the cryptocurrency fell. Bitcoin treasury company Strategy was down nearly7%, while trading platform Robinhood Markets dropped about 9% and Coinbase fell 7%. Stablecoin company Circle Internet slipped nealry 6%. Regeneron — The pharmaceutical company’s stock popped 4% after the Food and Drug Administration said it approved Eylea HD to treat macular edema after a retinal vein occlusion. Walmart — The retail giant rose almost 6% better-than-expected results for the third quarter. Walmart earned an adjusted 62 cents per share on revenue of $179.5 billion . Analysts expected a profit of 60 cents per share on revenue of $177.43 billion. The company also hiked its full-year sales outlook. Palo Alto Networks — The cybersecurity stock fell more than 6% after the company announced it will acquire cloud management company Chronosphere for $3.35 billion . This overshadowed Palo Alto Networks’ better-than-expected results for the fiscal first quarter. Oddity — Shares of the beauty and wellness company rallied 11% on third-quarter figures that beat analyst expectations. Oddity earned 40 cents per share, excluding certain items, on revenue of $148 million. Analysts polled by LSEG expected a profit of 35 cents per share on revenue of $145 million. The company also raised its full-year earnings outlook. Jacobs Solutions — The engineering and construction services company fell 9% despite fiscal fourth-quarter earnings that beat the Street. Jacobs Solutions earned $1.75 per share, excluding certain items, while analysts polled by FactSet expected a profit of $1.68 per share. The company’s forecast for fiscal 2026 also topped estimates. Solventum — Shares of the health-care company rose 4% after it said it would acquire Acera Surgical for $725 million in cash. The deal moves Solventum into the regenerative wound care market. Bath & Body Works — The American retailer of soaps and lotions tumbled more than 25% after posting disappointing third-quarter results. Earnings of 35 cents per share, on an adjusted basis, fell short of the 39 cents per-share earnings expected by analysts, according to FactSet. Revenue of $1.59 billion came in below the $1.63 billion consensus estimate. —CNBC’s Fred Imbert and Sarah Min contributed to this report.